Financhill
Back

Nurix Therapeutics Quote, Financials, Valuation and Earnings

Buy
80

NRIX
Nurix Therapeutics

Last Price:
16.58
Seasonality Move:
27.58%

7 Day Trial

ALL ACCESS PASS

$ 7

Nurix Therapeutics Price Quote

$16.58
-0.01 (7.66%)
(Updated: May 18, 2024 at 5:49 AM ET)

Nurix Therapeutics Key Stats

Buy
80
Nurix Therapeutics (NRIX) is a Buy

Day range:
$14.53 - $16.84
52-week range:
$4.22 - $18.12
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
11.19
P/B ratio:
6%

Volume:
3M
Avg. volume:
1.3M
1-year change:
65.73%
Market cap:
$1B
Revenue:
$77M
EPS:
$-2.66

How Much Does Nurix Therapeutics Make?

Is Nurix Therapeutics Growing As A Company?

  • What Is Nurix Therapeutics's Growth Rate Quarterly?
    Quarterly YoY revenue growth is 0.31%
  • What Is Nurix Therapeutics's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 0%

Nurix Therapeutics Stock Price Performance

What Is Nurix Therapeutics 52-Week High & Low?

Nurix Therapeutics Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Nurix Therapeutics?

Is Nurix Therapeutics Cash Flow Positive?

  • What Is NRIX Cash Flow From Operations?
    Cash flow from operations (TTM) is -$74.9M
  • What Is Nurix Therapeutics’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $3.4M
  • What Is Nurix Therapeutics’s Cash Flow From Investing?
    Cash flow from investing (TTM) is $87.7M

Nurix Therapeutics Return On Invested Capital

  • Is Management Doing A Good Job?
    NRIX return on invested capital is -63.65%
  • What Is Nurix Therapeutics Return On Assets?
    ROA measures how assets are converting to revenues and is -42.64%
  • What Is NRIX Return On Equity?
    ROE is a measure of profitability and is -63.65%

Nurix Therapeutics Earnings Date & Stock Price

Nurix Therapeutics Competitors

Nurix Therapeutics Dividend Yield

Data Unavailable

Nurix Therapeutics Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 3.9%
Revenue: 30.75% -2.93%

Analyst Recommendations

Buy Recommendations: 5
Hold Recommendations: 1
Sell Recommendations: 0
Price Target: 24.67
Upside from Last Price: 48.68%

Major Shareholders

  • How many NRIX shares are owned by institutional investors?
    60.6M NRIX shares are owned by institutional investors
  • How many NRIX shares are owned by insiders?
    537.4K NRIX shares are owned by insiders